Extended Data Fig. 7: T cell response to infectious disease epitopes does not correlate to tumor biomarker response or delayed tumor recurrence.

a, Best overall biomarker response for study participants reported as percentage of the baseline value, stratified by infectious disease epitope-specific T cell response (≥Median versus < Median), n = 23. Values depicted are mean ± standard deviation. P value calculated by two-tailed Mann-Whitney test. b, RFS from study start (date of first vaccine dose) stratified by infectious disease epitope-specific T cell response (≥Median versus < Median), n = 23. n indicates individual patients. HR indicates hazard ratio with 95% CI. P value calculated using two-tailed log-rank test.